MORBİD OBEZİTEDE AĞRI YÖNETİMİ
Synopsis
This chapter addresses perioperative and chronic pain management in morbid obesity. As global obesity rates rise rapidly, proinflammatory processes and adipokine release in obese individuals contribute to cardiovascular and metabolic diseases, as well as persistent pain. Impaired cognitive functions and sensory pathways complicate pain perception and scoring. For acute pain management, the World Health Organization (WHO) recommends a 4-step opioid-sparing approach. In the first step, agents like acetaminophen and ketorolac effectively reduce opioid consumption. While the second step includes tramadol and tapentadol, standard opioid use for severe pain should be restricted due to high risks of sedation and respiratory depression. Adjuvant non-opioid options—such as pregabalin, gabapentin, ketamine, dexmedetomidine, clonidine, and lidocaine—enhance analgesia while mitigating adverse effects. Regarding chronic pain post-bariatric surgery, the rise in persistent opioid use and dosage escalation poses a major concern, underscoring the need for optimized multimodal protocols and clear clinical guidelines.
References
Budiansky AS, Margarson MP, Eipe N. Acute pain management in morbid obesity - an evidence based clinical update. Surg Obes Relat Dis. 2017;13(3):523-32.
Apovian CM. Obesity: definition, comorbidities, causes, and burden. Am J Manag Care. 2016;22(7 Suppl):s176-85.
Kiliaan AJ, Arnoldussen IA, Gustafson DR. Adipokines: a link between obesity and dementia? Lancet Neurol. 2014;13(9):913-23.
Torensma B, Thomassen I, van Velzen M, et al. Pain Experience and Perception in the Obese Subject Systematic Review (Revised Version). Obes Surg. 2016;26(3):631-9.
Narouze S, Souzdalnitski D. Obesity and chronic pain: systematic review of prevalence and implications for pain practice. Reg Anesth Pain Med. 2015;40(2):91-111.
Torensma B, Oudejans L, van Velzen M, et al. Pain sensitivity and pain scoring in patients with morbid obesity. Surg Obes Relat Dis. 2017;13(5):788-95.
Dahan A, Brines M, Niesters M, et al. Targeting the innate repair receptor to treat neuropathy. Pain Rep. 2016;1(1):e566.
Oudejans L, van Velzen M, Olofsen E, et al. Translation of random painful stimuli into numerical responses in fibromyalgia and perioperative patients. Pain. 2016;157(1):128-36.
Zdziarski LA, Wasser JG, Vincent HK. Chronic pain management in the obese patient: a focused review of key challenges and potential exercise solutions. J Pain Res. 2015;8:63-77.
Remy C, Marret E, Bonnet F. Effects of acetaminophen on morphine side-effects and consumption after major surgery: meta-analysis of randomized controlled trials. Br J Anaesth. 2005;94(4):505-13.
Song K, Melroy MJ, Whipple OC. Optimizing multimodal analgesia with intravenous acetaminophen and opioids in postoperative bariatric patients. Pharmacotherapy. 2014;34 Suppl 1:14s-21s.
Madan AK, Ternovits CA, Speck KE, et al. Inpatient pain medication requirements after laparoscopic gastric bypass. Obes Surg. 2005;15(6):778-81.
Govindarajan R, Ghosh B, Sathyamoorthy MK, et al. Efficacy of ketorolac in lieu of narcotics in the operative management of laparoscopic surgery for morbid obesity. Surg Obes Relat Dis. 2005;1(6):530-5; discussion 5-6.
Klein M, Støckel M, Rosenberg J, et al. Intraoperative ketorolac and bleeding after laparoscopic Roux-en-Y gastric by-pass surgery. Acta Chir Belg. 2012;112(5):369-73.
Nossaman VE, Ramadhyani U, Kadowitz PJ, et al. Advances in perioperative pain management: use of medications with dual analgesic mechanisms, tramadol & tapentadol. Anesthesiol Clin. 2010;28(4):647-66.
Mattia C, Coluzzi F, Sarzi Puttini P, et al. Paracetamol/Tramadol association: the easy solution for mild-moderate pain. Minerva Med. 2008;99(4):369-90.
Castro DS, Jr., Leão P, Borges S, et al. Sugammadex reduces postoperative pain after laparoscopic bariatric surgery: a randomized trial. Surg Laparosc Endosc Percutan Tech. 2014;24(5):420-3.
Porhomayon J, Leissner KB, El-Solh AA, et al. Strategies in postoperative analgesia in the obese obstructive sleep apnea patient. Clin J Pain. 2013;29(11):998-1005.
Ramachandran SK, Haider N, Saran KA, et al. Life-threatening critical respiratory events: a retrospective study of postoperative patients found unresponsive during analgesic therapy. J Clin Anesth. 2011;23(3):207-13.
George JA, Lin EE, Hanna MN, et al. The effect of intravenous opioid patient-controlled analgesia with and without background infusion on respiratory depression: a meta-analysis. J Opioid Manag. 2010;6(1):47-54.
Choi YK, Brolin RE, Wagner BK, et al. Efficacy and safety of patient-controlled analgesia for morbidly obese patients following gastric bypass surgery. Obes Surg. 2000;10(2):154-9.
De Baerdemaeker LE, Jacobs S, Pattyn P, et al. Influence of intraoperative opioid on postoperative pain and pulmonary function after laparoscopic gastric banding: remifentanil TCI vs sufentanil TCI in morbid obesity. Br J Anaesth. 2007;99(3):404-11.
Bidgoli J, Delesalle S, De Hert SG, et al. A randomised trial comparing sufentanil versus remifentanil for laparoscopic gastroplasty in the morbidly obese patient. Eur J Anaesthesiol. 2011;28(2):120-4.
Mishriky BM, Waldron NH, Habib AS. Impact of pregabalin on acute and persistent postoperative pain: a systematic review and meta-analysis. Br J Anaesth. 2015;114(1):10-31.
Alimian M, Imani F, Faiz SH, et al. Effect of oral pregabalin premedication on post-operative pain in laparoscopic gastric bypass surgery. Anesth Pain Med. 2012;2(1):12-6.
Hassani V, Pazouki A, Nikoubakht N, et al. The effect of gabapentin on reducing pain after laparoscopic gastric bypass surgery in patients with morbid obesity: a randomized clinical trial. Anesth Pain Med. 2015;5(1):e22372.
Ho KY, Gan TJ, Habib AS. Gabapentin and postoperative pain--a systematic review of randomized controlled trials. Pain. 2006;126(1-3):91-101.
Laskowski K, Stirling A, McKay WP, et al. A systematic review of intravenous ketamine for postoperative analgesia. Can J Anaesth. 2011;58(10):911-23.
HM K. Ketamine as an adjuvant to morphine for patient controlled analgesia in morbidly obese patients. JMedSci. 2008.
Sollazzi L, Modesti C, Vitale F, et al. Preinductive use of clonidine and ketamine improves recovery and reduces postoperative pain after bariatric surgery. Surg Obes Relat Dis. 2009;5(1):67-71.
Feld JM, Laurito CE, Beckerman M, et al. Non-opioid analgesia improves pain relief and decreases sedation after gastric bypass surgery. Can J Anaesth. 2003;50(4):336-41.
Ziemann-Gimmel P, Goldfarb AA, Koppman J, et al. Opioid-free total intravenous anaesthesia reduces postoperative nausea and vomiting in bariatric surgery beyond triple prophylaxis. Br J Anaesth. 2014;112(5):906-11.
Weinbroum AA, Ben-Abraham R. Dextromethorphan and dexmedetomidine: new agents for the control of perioperative pain. Eur J Surg. 2001;167(8):563-9.
Tufanogullari B, White PF, Peixoto MP, et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesth Analg. 2008;106(6):1741-8.
Feld JM, Hoffman WE, Stechert MM, et al. Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. J Clin Anesth. 2006;18(1):24-8.
Naja ZM, Khatib R, Ziade FM, et al. Effect of clonidine versus dexmedetomidine on pain control after laparoscopic gastric sleeve: A prospective, randomized, double-blinded study. Saudi J Anaesth. 2014;8(Suppl 1):S57-62.
Chan AK, Cheung CW, Chong YK. Alpha-2 agonists in acute pain management. Expert Opin Pharmacother. 2010;11(17):2849-68.
De Oliveira GS, Jr., Duncan K, Fitzgerald P, et al. Systemic lidocaine to improve quality of recovery after laparoscopic bariatric surgery: a randomized double-blinded placebo-controlled trial. Obes Surg. 2014;24(2):212-8.
Blom-Høgestøl IK, Stubhaug A, Kristinsson JA, et al. Diagnosis and treatment of chronic abdominal pain 5 years after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2018;14(10):1544-51.
Szigethy E, Knisely M, Drossman D. Opioid misuse in gastroenterology and non-opioid management of abdominal pain. Nat Rev Gastroenterol Hepatol. 2018;15(3):168-80.
Coaccioli S, Masia F, Celi G, et al. [Chronic pain in the obese: a quali-quantitative observational study]. Recenti Prog Med. 2014;105(4):151-4.
Stone AA, Broderick JE. Obesity and pain are associated in the United States. Obesity (Silver Spring). 2012;20(7):1491-5.
Wright LJ, Schur E, Noonan C, et al. Chronic pain, overweight, and obesity: findings from a community-based twin registry. J Pain. 2010;11(7):628-35.
Thomazeau J, Perin J, Nizard R, et al. Pain management and pain characteristics in obese and normal weight patients before joint replacement. J Eval Clin Pract. 2014;20(5):611-6.
Birke H, Ekholm O, Sjøgren P, et al. Long-term opioid therapy in Denmark: A disappointing journey. Eur J Pain. 2017;21(9):1516-27.
Simoni AH, Ladebo L, Christrup LL, et al. Chronic abdominal pain and persistent opioid use after bariatric surgery. Scand J Pain. 2020;20(2):239-51.
Horsley RD, Vogels ED, McField DAP, et al. Multimodal Postoperative Pain Control Is Effective and Reduces Opioid Use After Laparoscopic Roux-en-Y Gastric Bypass. Obes Surg. 2019;29(2):394-400.
Raebel MA, Newcomer SR, Reifler LM, et al. Chronic use of opioid medications before and after bariatric surgery. Jama. 2013;310(13):1369-76.
Smith ME, Lee JS, Bonham A, et al. Effect of new persistent opioid use on physiologic and psychologic outcomes following bariatric surgery. Surg Endosc. 2019;33(8):2649-56.
Raebel MA, Newcomer SR, Bayliss EA, et al. Chronic opioid use emerging after bariatric surgery. Pharmacoepidemiol Drug Saf. 2014;23(12):1247-57.